News about Global Pharma

GSK Secures FDA Approval for Prefilled Syringe Version of Shingles Vaccine Shingrix

GSK has received approval from the US Food and Drug Administration (FDA) for a new prefilled syringe presentation of Shingrix (Recombinant Zoster Vaccine, RZV), designed to prevent shingles (herpes zoster).

Global Pharma | 17/07/2025 | By Dineshwori |  545

Johnson and Johnson Reports Over 18 Percent Jump in Q2 Earnings

Johnson and Johnson has reported its second-quarter 2025 results, with net earnings soaring 18.2 percent to USD 5.54 billion, up from USD 4.69 billion in the same period last year.

Global Pharma | 17/07/2025 | By Dineshwori |  281

Amphastar to Expand US Manufacturing Footprint, Quadruple Production Capacity

Amphastar Pharmaceuticals aims to quadruple its production capacity at its headquarters in Rancho Cucamonga, California over the next three to five years.

Global Pharma | 16/07/2025 | By Dineshwori |  238

FDA to Review GSK's Application to Expand Arexvy RSV Vaccine Use

The US Food and Drug Administration (FDA) has accepted to review GlaxoSmithKline (GSK)'s application to expand the use of its RSV vaccine, Arexvy, to include adults aged 18–49 who are at increased risk.

Global Pharma | 16/07/2025 | By Dineshwori |  287

Biocon Biologics Secures FDA Approval for Kirsty

Biocon Biologics has announced that it has received FDA approval for KIRSTY (Insulin Aspart-xjhz), making it the first and only interchangeable biosimilar to NovoLog in the US, marking a major milestone in expanding affordable insulin options.

Global Pharma | 16/07/2025 | By Mrinmoy Dey |  315

Emcure Pharma Taps Industry Veteran R.S. Vasan to Lead India Business

Emcure Pharmaceuticals Ltd. has appointed R.S. Vasan as President – India Business and Senior Management Personnel (SMP).

Global Pharma | 16/07/2025 | By Dineshwori |  497

MPP-ViiV Agreement Expanded: Aurobindo, Cipla and Viatris to Make Generic HIV Drug Cabotegravir

ViiV Healthcare and the Medicines Patent Pool (MPP) have expanded their voluntary licensing agreement for cabotegravir, enabling manufacturers such as Aurobindo, Cipla, and Viatris to develop, manufacture, and supply generic versions for the HIV treatment in 133 countries.

Global Pharma | 15/07/2025 | By Dineshwori |  545

Jubilant Ingrevia Appoints Kailash Ukhade as Vice President - Projects

Jubilant Ingrevia Ltd. has announced the appointment of Kailash Ukhade as Vice President – Projects, based in Bharuch.

Global Pharma | 15/07/2025 | By Dineshwori |  251

Evonik Opens New Medical Device Application Center in Shanghai to Serve Asian Market

The Evonik Shanghai Medical Device Center is designed to help manufacturers tackle complex challenges and accelerate innovation in medical technologies.

Global Pharma | 14/07/2025 | By Dineshwori |  345

Senores Pharmaceuticals Inks SPA to Raise Stake in Havix

Senores Pharmaceuticals Ltd. (SPL) has entered into a Share Purchase Agreement (SPA) with a public shareholder of Havix Group Inc., doing business as Aavis Pharmaceuticals (Havix), to acquire 6,730 equity shares — representing 2.97 percent of Havix’s total paid-up share capital.

Global Pharma | 14/07/2025 | By Dineshwori |  398